- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02159391
The Efficacy of Brief Motivational Interviewing for Trauma Patients Related to Alcohol or Other Abuse Drugs. (MOTIVA)
September 24, 2015 updated by: Raquel Vilar Lopez, Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
The purpose of this study is to determine whether the Brief Motivational Interview will produce a significantly reduction in risk behavior than usual treatment 3 months after discharge from hospital in people who have survived a traumatism.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Objectives:
- To determine the efficacy of Brief Motivational Interview against an usual hospital treatment (no psychological treatment) in patients who have suffered an accident under the influence of drugs (1) to reduce risk behaviors and drug consumption and (2) to increase motivation to change behavior and risk perception.
- To investigate the mediating role of impulsive personality and decision making in the impact of Brief Motivational Interview on reduction of risk driving.
- To assess the economic viability of the results of Brief Motivational Interview through a cost-utility analysis.
Study Type
Interventional
Enrollment (Anticipated)
86
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Andalucia
-
Granada, Andalucia, Spain, 18000
- Hospital Virgen de las Nieves
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Trauma patients who have had: 1) A road crash, 2) A sport injury, 3) Occupational accident.
- Tested positive on alcohol and/or other abuse drugs tests.
Exclusion Criteria:
- Cognitive or brain-damage that prevent assessment and Brief Motivational Interview
- Psychopathological disorders
- Residence status that prevents follow-up (residence outside of Spain, homeless).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Usual Intervention
A standard intervention will be performed by nursing staff during hospital admission.
Written information about the consequences of driving under the influence of alcohol and/or drugs will be provided.
No psychological intervention.
|
|
Experimental: Brief Motivational Interview
A Brief Motivational Interviewing will be performed during hospital admission by a psychologist experienced with this intervention.
|
The Brief Motivational Interview implies an empathic interviewing style which (i) recognizes, examines and tries to resolve the patient´s ambivalence to facilitate behavioral change, (ii) promotes self-efficacy, (iii) allows flexibility in strategies, including short-term aims to reduce consumption and decrease damage linked to this consumption (like road accidents), (iv) works to reduce the patient's resistances, and (v) provides individualized feedback, if deemed appropriate, to promote recognition of the problem and cognitive restructuring.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Risk behavior
Time Frame: Baseline, month 3.
|
Measure with Short Driver Behaviour Questionnaire (SDBQ) and Domain-Specific Risk-Taking (DOSPERT)
|
Baseline, month 3.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Alcohol and Other Drug consumption
Time Frame: Baseline, month 3.
|
Measure with Timeline Followback (TLFB), Interview for Research on Addictive Behavior (IRAB) and Audit Test.
|
Baseline, month 3.
|
Motivation to change
Time Frame: Baseline, post-intervention, month 3
|
Measure with SOCRATES-8
|
Baseline, post-intervention, month 3
|
Risk perception
Time Frame: Baseline, post-intervention, month 3.
|
Risk perception questionnaire, perceived risk of alcohol and drug (EDADES).
|
Baseline, post-intervention, month 3.
|
General Health
Time Frame: Baseline, month 3.
|
Measure with SF6D
|
Baseline, month 3.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Risk Taking and Impulsive Behavior
Time Frame: Baseline, month 3.
|
Measure with Impulsive Behavior Scale (UPPS-P) and Self-efficacy questionnaire
|
Baseline, month 3.
|
Real-life decision making
Time Frame: Baseline, month 3.
|
Iowa Gambling Task (IGT)
|
Baseline, month 3.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Raquel Vilar, PhD, Universidad de Granada
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2014
Primary Completion (Anticipated)
March 1, 2016
Study Completion (Anticipated)
December 1, 2016
Study Registration Dates
First Submitted
June 6, 2014
First Submitted That Met QC Criteria
June 6, 2014
First Posted (Estimate)
June 9, 2014
Study Record Updates
Last Update Posted (Estimate)
September 25, 2015
Last Update Submitted That Met QC Criteria
September 24, 2015
Last Verified
September 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PI 0691-2013
- PI-0691-2013 (Other Identifier: JUNTA DE ANDALUCIA)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on AODD and AODR Disorder
-
Instituto Nacional de Psiquiatría Dr. Ramón de...CompletedDrug-withdrawal. | Drug Abuse | Drug-induced Depressive State | AOD Craving | AODR Depressive StateMexico
-
University of Illinois at ChicagoNational Institute of Mental Health (NIMH)RecruitingMood Disorders | Major Depressive Disorder | Bipolar Disorder I | Bipolar Disorder II | Persistent Depressive Disorder (Dysthymia) | CyclothymiaUnited States
-
Samsung Medical CenterUnknownMajor Depressive Disorder, Anxiety DisorderKorea, Republic of
-
Weill Medical College of Cornell UniversityCompletedSchizoaffective Disorder | Obsessive-Compulsive Disorder | Major Depressive Disorder | Posttraumatic Stress Disorder | Social Anxiety Disorder | Panic Disorder | Premenstrual Dysphoric Disorder | Dysthymic Disorder | Cyclothymic Disorder | Bipolar Affective DisordersUnited States
-
Adams ClinicalRecruitingGeneralized Anxiety Disorder | Major Depressive Disorder | Borderline Personality DisorderUnited States
-
ProgenaBiomeRecruitingBipolar Disorder | Bipolar I Disorder | Bipolar II Disorder | Bipolar Type I Disorder | Bipolar Disorder Mild | Bipolar Disorder Moderate | Bipolar Disorder SevereUnited States
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do Sul; Hospital Moinhos de VentoActive, not recruitingBipolar Disorder | Bipolar Depression | Major Depressive Disorder | Bipolar I Disorder | Affective Disorder | Bipolar II DisorderBrazil
-
Babes-Bolyai UniversityCompletedAnxiety Disorders | Generalized Anxiety Disorder | Major Depressive Disorder | Social Anxiety Disorder | Panic Disorder | Persistent Depressive DisorderRomania
-
Beijing Tongren HospitalBeijing Winsunny Pharmceutical Co.,Ltd.CompletedObsessive-Compulsive Disorder | Generalized Anxiety Disorder | Major Depressive Disorder | Social Anxiety Disorder | Panic DisorderChina
-
Nova Scotia Health AuthorityTerminatedGeneralized Anxiety Disorder | Major Depressive Disorder | Social Anxiety Disorder | Panic DisorderCanada
Clinical Trials on Brief Motivational Interview
-
University of California, DavisSacramento Police Department; California Office of Traffic SafetyCompleted
-
Boston UniversityU.S. Department of JusticeCompletedSexual Aggression | Offensive Aggression | Dating Violence Perpetration and VictimizationUnited States
-
University of California, DavisUniversity of Michigan; Robert Wood Johnson Foundation; Sacramento Police Department and other collaboratorsCompleted
-
Brigham and Women's HospitalCompletedMotivational Interviewing | Advance Care Planning | Emergency Service, HospitalUnited States
-
University of California, DavisCalifornia Office of Traffic SafetyActive, not recruitingAlcohol Drinking | Wounds and InjuriesUnited States
-
University of Texas, El PasoPatient-Centered Outcomes Research InstituteTerminatedAlcohol ConsumptionUnited States
-
The University of Hong KongUnknown
-
Boston Medical CenterCompletedSexually Transmitted InfectionUnited States
-
The City College of New YorkNational Institute on Drug Abuse (NIDA)CompletedHIV PreventionSouth Africa
-
Brown UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Enrolling by invitationAlcohol Drinking | Alcohol; Harmful UseUnited States